Similar articles for PMID: 1944276

Year	Number of Results
1989	1
1990	2
1991	2
1992	11
1993	16
1994	10
1995	5
1996	6
1997	5
1998	6
1999	7
2000	4
2001	11
2002	3
2003	4
2004	2
2005	2
2006	1
2007	1
2008	1
2009	2
2011	1
2019	1
2021	1
2024	0

1

Analysis of p53 mutants for transcriptional activity.

Raycroft L, Schmidt JR, Yoas K, Hao MM, Lozano G. Raycroft L, et al. Mol Cell Biol. 1991 Dec;11(12):6067-74. doi: 10.1128/mcb.11.12.6067-6074.1991. Mol Cell Biol. 1991. PMID: 1944276 Free PMC article.

2

Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription.

Miller CW, Chumakov A, Said J, Chen DL, Aslo A, Koeffler HP. Miller CW, et al. Oncogene. 1993 Jul;8(7):1815-24. Oncogene. 1993. PMID: 8510927

3

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.

Raycroft L, Wu HY, Lozano G. Raycroft L, et al. Science. 1990 Aug 31;249(4972):1049-51. doi: 10.1126/science.2144364. Science. 1990. PMID: 2144364 Free PMC article.

4

p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.

Unger T, Nau MM, Segal S, Minna JD. Unger T, et al. EMBO J. 1992 Apr;11(4):1383-90. doi: 10.1002/j.1460-2075.1992.tb05183.x. EMBO J. 1992. PMID: 1314165 Free PMC article.

5

The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.

Liu X, Miller CW, Koeffler PH, Berk AJ. Liu X, et al. Mol Cell Biol. 1993 Jun;13(6):3291-300. doi: 10.1128/mcb.13.6.3291-3300.1993. Mol Cell Biol. 1993. PMID: 8497252 Free PMC article.

6

Mammalian p53 can function as a transcription factor in yeast.

Schärer E, Iggo R. Schärer E, et al. Nucleic Acids Res. 1992 Apr 11;20(7):1539-45. doi: 10.1093/nar/20.7.1539. Nucleic Acids Res. 1992. PMID: 1579447 Free PMC article.

7

A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.

Lin SR, Yang YC, Jung JH, Tsai JH. Lin SR, et al. DNA Cell Biol. 1996 Oct;15(10):793-803. doi: 10.1089/dna.1996.15.793. DNA Cell Biol. 1996. PMID: 8892752

8

A functionally inactive p53 Li-Fraumeni syndrome mutant.

Hao M, Finlay CA, Lozano G. Hao M, et al. Oncogene. 1993 Feb;8(2):299-306. Oncogene. 1993. PMID: 8426739

9

Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.

Kühnel F, Zender L, Wirth T, Schulte B, Trautwein C, Manns M, Kubicka S. Kühnel F, et al. Cancer Gene Ther. 2004 Jan;11(1):28-40. doi: 10.1038/sj.cgt.7700632. Cancer Gene Ther. 2004. PMID: 14681724

10

A potential transcriptional activation element in the p53 protein.

O'Rourke RW, Miller CW, Kato GJ, Simon KJ, Chen DL, Dang CV, Koeffler HP. O'Rourke RW, et al. Oncogene. 1990 Dec;5(12):1829-32. Oncogene. 1990. PMID: 2284102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year